toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Li, M., Xiao, A., Floyd, D., Olmez, I., Lee, J., Godlewski, J., et al. (2017). CDK4/6 inhibition is more active against the glioblastoma proneural subtype. Oncotarget, 8(33), 55319–55331.
toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print